By Damilola Samuel
President Bola Ahmed Tinubu has approved N302.3 billion for the construction and equipping of a National Cancer institute, a move excepted to specialised cancer treatment, research and training in Nigeria.
The purpose-built institute, which is expected to be completed within 36 months, is designed to bring advanced cancer diagnosis and treatment together with research, innovation and professional training.
The investment is also expected to address the growing dependence on overseas treatment by Nigerians seeking specialised cancer services.
According to the press statement posted on his X handle, the institute will provide highly specialised services locally, with the expectation that fewer Nigerians will need to travel abroad for cancer treatment. It could also create opportunities for Nigeria to attract patients, researchers and medical professionals from other African countries.
The project will serve as more than a conventional treatment facility, with plans for clinical trials, evidence-based health policies and the training and retraining of oncology professionals across Africa.
The statement described the initiative as an investment in Nigeria’s ability to deliver advanced healthcare locally.
“For President Tinubu, this is about more than constructing another medical facility. It is an investment in life-saving healthcare, medical research, human capital and Nigeria’s capacity to provide world-class treatment at home.”
The institute will complement the ongoing upgrade of cancer treatment centres in Katsina, Benin and Enugu as part of efforts to strengthen the country’s wider oncology infrastructure.
The project is also expected to help Nigeria retain more healthcare spending within the country while building capacity in cancer research and treatment.
The statement said the N302.3 billion commitment was consistent with the Renewed Hope Agenda’s focus on improving the health sector and reducing the need for Nigerians to seek advanced medical care outside the country.
It added that the investment would help give Nigerians “greater access to quality cancer care” while positioning the country as a potential centre for oncology excellence in Africa.
However, the statement stressed that the success of the investment would depend on effective management of public resources, accurate records and strong financial controls.
“The management of public resources requires accurate records and effective controls,” it stated, warning that leakages and access to public funds by illegitimate entities could divert resources meant for government priorities.
The institute is therefore expected to combine infrastructure with medical expertise, research and innovation as Nigeria seeks to strengthen its cancer-care system and reduce medical tourism.
